You are here » Home » Markets » Mutual Funds

Nippon India Pharma Fund - Direct (G)

Fund Class : Equity - Pharma
Fund House : Nippon India Mutual Fund
Aum(Rs Cr) : 653.56
NAV 01 Jul 2022 285.01 2.36
(0.83%)

NAV High-Low (in Rs)

ONE Mth
52-WEEk 4515.92
5667.10

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes 0.77 - - - 23.62
Sensex 0.34 -4.47 -9.18 1.13 33.31
Nifty 0.34 -4.66 -9.23 0.46 32.75

Fund Features

Types of Scheme Growth
Options Equity
Assets Size (Rs in Cr) 653.56 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 0.00.

Fund Activity

   As On 31 May 2022
Category Share (%)
Cash & Cash Equivalent 0.01
Equity 98.33
Reverse Repo 1.96
› More
   As On 31 May 2022
Sector Name Amount
Healthcare 17.38
Miscellaneous 0.61
NA 1.97
Pharmaceuticals - Indian - Bulk Drugs 17.11
Pharmaceuticals - Indian - Bulk Drugs & Formln 50.74
Pharmaceuticals - Indian - Formulations 0.58
Pharmaceuticals - Multinational 11.91
› More
   As On 31 May 2022
Company Name
Sun Pharma.Inds. 13.91
Cipla 9.23
Dr Reddy's Labs 7.74
Divi's Lab. 6.89
Torrent Pharma. 6.63
Narayana Hrudaya 6.00
Lupin 5.89
Abbott India 5.86
› More

Fund DETAILS

Asset Management Co.

Registered Address

Nippon Life India Asset Management Ltd,

4th Floor Tower A Peninsula Busines
-s Park Ganapatrao Kadam Marg
Lower Parel (W) Mumbai - 400013.

Phone: 022-68087000/1860260111 | Fax: 022-68087097

Email: customercare@nipponindiaim.in

Website: mf.nipponindiaim.com

.